Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» epilepsy
epilepsy
Praxis’ epilepsy drug hits in phase 2, sparking stock rise and plans for next trial
Fierce Biotech
Tue, 03/26/24 - 11:34 am
Praxis Precision Medicines
clinical trials
PRAX-628
epilepsy
Neurona raises another $120M for brain disease cell therapies
BioPharma Dive
Thu, 02/8/24 - 09:55 pm
Neurona
funding
epilepsy
cell therapy
Xenon’s Add-On Epilepsy Treatment Shows Promising Phase IIb Efficacy, Safety
BioSpace
Tue, 10/10/23 - 11:33 am
Xenon
epilepsy
clinical trials
XEN1101
Stoke faces new doubts in search for ‘Spinraza for epilepsy’
BioPharma Dive
Tue, 07/25/23 - 08:47 pm
Stoke Therapeutics
Dravet syndrome
epilepsy
STK-001
Neurona’s brain stem cell therapy shows early efficacy in epilepsy
Clinical Trials Arena
Thu, 06/15/23 - 06:54 pm
Neurona
stem cells
epilepsy
clinical trials
Cerevel blames Covid for delayed neuroscience studies, says president is leaving
Endpoints
Fri, 02/24/23 - 09:12 am
Cerevel Therapeutics
COVID-19
epilepsy
Parkinson's Disease
darigabat
CVL-871
With bigger fish to fry, Eisai unloads US rights to epilepsy drug Fycompa to Catalyst
Fierce Pharma
Tue, 12/20/22 - 11:14 am
Eisai
Fycompa
Catalyst Pharmaceuticals
epilepsy
Praxis ends year on high with $100M biobucks UCB deal for epilepsy medicine
Fierce Biotech
Wed, 12/14/22 - 07:40 pm
Praxis
UCB Pharma
epilepsy
PRAX-020
Biohaven fuels up for post-Pfizer future with $302M fundraising, fresh faces in the C-suite
Fierce Biotech
Wed, 11/9/22 - 10:41 am
Biohaven
Pfizer
funding
epilepsy
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays
Fierce Biotech
Tue, 10/4/22 - 11:45 pm
Pfizer
Biohaven
migraines
epilepsy
Ovid takes a novel approach to gene therapy
EP Vantage
Thu, 08/25/22 - 10:54 am
Ovid Therapeutics
gene therapy
epilepsy
phages
Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial
BioSpace
Thu, 08/18/22 - 12:45 pm
Jazz Pharma
Epidiolex
clinical trials
pediatrics
epilepsy
cannabindoids
After rejection, Azurity gets FDA nod for liquid epilepsy drug
Fierce Pharma
Tue, 07/19/22 - 10:30 am
Azurity
FDA
zonisamide
epilepsy
French court rules against Sanofi in landmark Depakine case
Endpoints
Tue, 05/17/22 - 10:33 am
legal
Sanofi
France
Depakine
epilepsy
birth defects
pregnancy
FDA tells Praxis it can't move into the clinic just yet for a rare epilepsy drug
Endpoints
Fri, 04/29/22 - 10:45 am
Praxis Precision Medicines
FDA
clinical hold
epilepsy
PRAX-222
Controversial opioid Zohydro ER pulled from the market
Endpoints
Thu, 02/3/22 - 12:00 am
UCB Pharma
epilepsy
Zogenix
Zohydro ER
Ovid signs license deal with AstraZeneca to expand epilepsy drug pipeline
Pharmaceutical Business Review
Tue, 01/4/22 - 10:16 am
Ovid Therapeutics
AstraZeneca
small molecule drugs
epilepsy
Canada's Xenon touts out-of-the-blue win for its daily epilepsy pill, sending investors into a frenzy
Endpoints
Mon, 10/4/21 - 11:05 am
Xenon
epilepsy
XEN-1101
clinical trials
Neuroelectrics gets $17M for new take on electrical therapy for epilepsy, depression
MedCity News
Wed, 05/5/21 - 10:48 am
Neuroelectrics
electrical therapy
devices
wearables
funding
epilepsy
Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy
Stat
Wed, 02/3/21 - 10:58 am
Jazz Pharma
GW Pharma
M&A
CBD
epilepsy
Epidiolex
Pages
1
2
3
4
5
6
7
8
9
next ›
last »